Terms ending in 2036
Every in-force patent on Agena Bioscience, Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,513,728 | Multiplexed Method for the Identification and Quantitation of Minor Alleles and Polymorphisms In force · High confidence | Agena Bioscience, Inc. | In force | High confidence | |
| US 10,865,439 | Multiplexed Method for the Identification and Quantitation of Minor Alleles and Polymorphisms In force · High confidence | Agena Bioscience, Inc. | In force | High confidence | |
| US 11,680,289 | Multiplexed Method for the Identification and Quantitation of Minor Alleles and Polymorphisms In force · High confidence | Agena Bioscience, Inc. | In force | High confidence | |
| US 12,454,722 | Multiplexed Method for the Identification and Quantitation of Minor Alleles and Polymorphisms In force · High confidence | Agena Bioscience, Inc. | In force | High confidence | |
| US 10,640,817 | Multiplex Methods for Detection and Quantification of Minor Variants In force · High confidence | Agena Bioscience, Inc. | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.